BUY!
Target Order: 148.48 EUR
Stop Order: 120.03 EUR
1.) GoodNEWS for Moderna: The British government wants to continue its course in the fight against the coronavirus. The first deliveries from the pharmaceutical company Moderna are expected in April, told member Oliver Dowden today. It would be the third vaccine to be used in the UK. To date, more than 30 million adults - 57% - have received a first dose.
2.) M30 chart shows a support level at the current price range. A rejection is expected.
3.) Execute the trade based on the recommended TP and SL levels!
4.) SL below last significant low!
Target Order: 148.48 EUR
Stop Order: 120.03 EUR
1.) GoodNEWS for Moderna: The British government wants to continue its course in the fight against the coronavirus. The first deliveries from the pharmaceutical company Moderna are expected in April, told member Oliver Dowden today. It would be the third vaccine to be used in the UK. To date, more than 30 million adults - 57% - have received a first dose.
2.) M30 chart shows a support level at the current price range. A rejection is expected.
3.) Execute the trade based on the recommended TP and SL levels!
4.) SL below last significant low!
거래청산: 스탑 닿음
SL was too optimistic
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.